spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Cellular Matrix 

 HSMN NewsFeed - 19 Apr 2024
Legacy Medical Consultants Announces Reeva FT(TM), a Full-Thickness Allograft for Wound Covering and Protection During Treatment
Devices Wound Care Product Launch Reimbursement
 HSMN NewsFeed - 6 Feb 2024
FDA Clears Groundbreaking Corplex P(TM): The First Human Umbilical Cord-Derived Medical Device
Devices Wound Care FDA
 HSMN NewsFeed - 16 Jun 2023
VIVEX Biologics, Inc. Launches New CYGNUS(R) Dual Amniotic Allograft
Devices Wound Care Product Launch
 HSMN NewsFeed - 11 May 2022
Acera Surgical Announces Michael Finegan as New CEO
Devices Surgery Wound Care Personnel
 HSMN NewsFeed - 28 Mar 2022
Spine BioPharma Completes Series B Financing
Biopharmaceuticals Orthopaedic Venture Capital
 HSMN NewsFeed - 1 Apr 2021
SkinMedica(R) Launches Neck Correct Cream for Neck and Décolleté
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 25 Aug 2020
DiscGenics Raises $50 Million in Series C Funding
Regenerative Medicine Orthopaedic Venture Capital
 HSMN NewsFeed - 8 Apr 2020
Soliton Granted New Key Patent for FDA Cleared RAP Technology
Devices
 HSMN NewsFeed - 1 Apr 2020
Soliton Announces New Launch Plan of Next Generation Acoustic Shockwave Product Due to COVID-19
Devices Dermatology Product Launch
 HSMN NewsFeed - 11 Mar 2020
Soliton Receives FDA Clearance of Special 510(k)
Devices Dermatology FDA
 HSMN NewsFeed - 11 Feb 2020
Soliton Files Special 510(k) with FDA for its Generation II RAP Device
Devices Dermatology FDA
 HSMN NewsFeed - 30 Jan 2020
Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care Partnership
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 10 Dec 2019
Soliton Appoints Mary Stoll as Senior Director of Clinical Development
Devices Dermatology Personnel
 HSMN NewsFeed - 29 Oct 2019
Soliton's Recent Positive Data Increases Potential Fibrotic Indications
Devices Dermatology
 HSMN NewsFeed - 3 Apr 2019
CSA Medical, Inc. Receives FDA Breakthrough Device Designation and IDE Approval for its RejuvenAir(R) System for COPD Patients with Chronic Bronchitis
Devices FDA
 HSMN NewsFeed - 28 Jan 2019
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Nov 2018
Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.
Devices Wound Care Mergers & Acquisitions
 HSMN NewsFeed - 8 Oct 2018
CSA Medical Secures $23 Million to Advance its Cryospray(TM) Therapies for Esophageal Disease and COPD
Devices Venture Capital
 HSMN NewsFeed - 31 May 2018
TELA Bio(R) Announces Plans to Launch OviTex(R) Reinforced BioScaffolds in Europe
Devices Surgery Product Launch
 HSMN NewsFeed - 11 Apr 2018
ACell, Inc. Announces Launch of Gentrix(R) Incisional
Devices Surgery Product Launch
 HSMN NewsFeed - 3 Apr 2018
Improving Cardiology Care: BIOTRONIK US to Distribute Aziyo ECM Envelopes
Devices Cardiology Distribution
 HSMN NewsFeed - 22 Jan 2018
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2017
Symic Bio Appoints Wayne Froland, Ph.D., as Executive Vice President of Technical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Oct 2017
DiscGenics Receives FDA Allowance of IND to Commence Clinical Study of Its Degenerative Disc Disease Therapy
Devices Regenerative Medicine Orthopaedic FDA
 HSMN NewsFeed - 20 Jan 2017
Osiris Therapeutics announced a Comparative Effectiveness Study on the Use of Two Human Placental Membranes in Wound Management is Available Electronically in a Peer-Reviewed Journal
Devices Wound Care
 HSMN NewsFeed - 2 Nov 2016
Verastem Licenses Duvelisib from Infinity Pharmaceuticals
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 1 Nov 2016
miRagen Therapeutics and Signal Genetics Sign Merger Agreement
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 23 Sep 2016
Biologica Technologies(R) launches Allofill(TM) injectable adipose filler at the annual gathering for the American Society of Plastic Surgeons (ASPS)
Devices Dermatology Product Launch
 HSMN NewsFeed - 28 Jul 2016
Derma Sciences to Acquire BioD, Solidify Its Leadership Position in Advanced Wound Care and Regenerative Products
Regenerative Medicine Wound Care Mergers & Acquisitions
 HSMN NewsFeed - 13 Jul 2016
TELA Bio Announces Commercial Launch of OviTex(TM) Reinforced BioScaffolds for Ventral Hernia Repair and Abdominal Wall Reconstruction
Devices Surgery Product Launch
 HSMN NewsFeed - 21 Jun 2016
CorMatrix(R) Cardiovascular, Inc. Treats First Patients with New Tyke(R) Product for Neonates and Infants
Devices Cardiology
 HSMN NewsFeed - 6 May 2016
Application of Fish Skin to Open Wounds Improves Healing
Regenerative Medicine Wound Care
 HSMN NewsFeed - 21 Apr 2016
Symic Appoints Kathleen Gogas, Ph.D., as VP of Preclinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Mar 2016
Ember Therapeutics Enhances Regenerative Medicine Pipeline With Acquisition of ICX-RHY/Vavelta(TM) from Intercytex
Regenerative Medicine Dermatology Acquisitions
 HSMN NewsFeed - 2 Mar 2016
Asana Medical, Inc. Names Dr. Christine V. Sapan CEO, Adds University of Miami's Sergio M. Gonzalez to Its Board of Directors
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 9 Feb 2016
CorMatrix Cardiovascular Inc. Receives 510(k) Clearance for its Tyke(TM) Implantable Device for Neonate and Infant Cardiac Tissue Repair
Devices Cardiology FDA
 HSMN NewsFeed - 29 Jan 2016
Human Regenerative Technologies, LLC (HRT) Announce WoundEx(R) Amniotic Membrane Products Receive Coverage From Novitas Solutions, Inc.
Devices Regenerative Medicine Reimbursement
 HSMN NewsFeed - 1 Jan 2016
Lattice Biologics Completes Merger With Blackstone Ventures
Devices Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 10 Nov 2015
miRagen Therapeutics Secures $41 million Series C Financing to Advance Two MicroRNA Programs into Clinical Trials
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jun 2015
XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 Jul 2014
CorMatrix(R) Reports FDA Clearance of CorMatrix ECM(R) for Vascular Repair
Devices Regenerative Medicine FDA
 HSMN NewsFeed - 21 May 2014
Baxter Provides U.S. Regulatory Update on HyQvia, Its Investigational Subcutaneous Treatment for Primary Immunodeficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Feb 2014
ACell Launches New MatriStem(R) Multilayer Wound Matrix Device
Devices Regenerative Medicine Wound Care Product Launch
 HSMN NewsFeed - 17 Jan 2014
Shire Executes Agreement to Divest DERMAGRAFT(R)
Devices Wound Care Acquisitions
 HSMN NewsFeed - 14 Jan 2014
Derma Sciences Enters the Skin Substitute Market with Licensing Agreement for Innovative Amniotic Membrane Wound Care Products
Devices Wound Care Licensing
 HSMN NewsFeed - 29 Nov 2013
Osiris Provides Update on Proposed Ruling by CMS
Devices Regenerative Medicine Wound Care Reimbursement
 HSMN NewsFeed - 24 Apr 2013
ACell MatriStem(R) Products Demonstrated to be Effective on Hard to Heal Wounds
Devices Regenerative Medicine Wound Care
 HSMN NewsFeed - 1 Mar 2013
Osiris Therapeutics Establishes Direct Sales Force for Grafix(R)
Devices Regenerative Medicine Wound Care Distribution
 HSMN NewsFeed - 18 Sep 2012
Alphatec Spine Releases Alphatec NEXoss(TM) Nanostructure Bio-Active Matrix and Announces the First Patient Implant
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 26 Mar 2012
CorMatrix Adds John Davis as Executive Vice President of Sales and Marketing
Devices Cardiology Regenerative Medicine Personnel
 HSMN NewsFeed - 12 Mar 2012
Organogenesis Inc. Announces FDA Approval of GINTUIT(TM) for Oral Soft Tissue Regeneration
Regenerative Medicine Wound Care FDA
 HSMN NewsFeed - 5 Jan 2012
Biomerix Receives CE Mark Approval For ASSURE Soft Tissue Repair Mesh
Devices Surgery Regenerative Medicine Regulatory
 HSMN NewsFeed - 16 Nov 2011
CorMatrix Receives Full IDE Approval for the Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Patients Receiving the CorMatrix(R) ECM(R) for Pericardial Closure
Devices Cardiology
 HSMN NewsFeed - 18 Oct 2011
Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Oct 2011
CorMatrix Receives Carotid Artery Repair Indication for its CorMatrix(R) ECM(R)
Devices FDA
 HSMN NewsFeed - 13 Apr 2011
Medline Premier Contract for Surgical Mesh Biomaterials Expanded to Include Revive(R) and Assure(R) Soft Tissue Repair Mesh
Devices Surgery Group Purchasing
 HSMN NewsFeed - 16 Feb 2011
Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial With Subcutaneous MabThera(R) (rituximab)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2011
Biomerix Granted CE Mark for its REVIVE Soft Tissue Repair Mesh
Devices Surgery Regulatory
 HSMN NewsFeed - 20 Dec 2010
Gilead Sciences to Acquire Arresto Biosciences for $225 Million
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Dec 2010
Halozyme Therapeutics Realigns Management
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 25 Oct 2010
Study Finds Correlation Between Pericardial Reconstruction with CorMatrix ECM(TM) Technology and Reduced Risk of Postoperative Atrial Fibrillation in CABG Patients
Devices Cardiology
 HSMN NewsFeed - 24 Jun 2010
Kensey Nash and Arthrex Announce Strategic Agreement for Extracellular Matrix Products
Devices Orthopaedic Regenerative Medicine
 HSMN NewsFeed - 23 Jun 2010
Kensey Nash Announces New Collagen Supply Agreement With St. Jude Medical
Devices Interventional
 HSMN NewsFeed - 15 Jun 2010
CorMatrix(R) ECM(TM) Receives CE Mark for Cardiac Tissue Repair
Devices Regenerative Medicine Cardiology Regulatory
 HSMN NewsFeed - 26 May 2010
KENSEY NASH Receives FDA 510(k) Clearance for ECM Product, Meso BioMatrix Surgical Mesh
Devices Surgery FDA
 HSMN NewsFeed - 17 May 2010
Halozyme Announces Voluntary Recall of HYLENEX(R)
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 5 Oct 2009
Baxter Announces the Commercial Launch of HYLENEX at ACEP for Use in Pediatric Rehydration
Biopharmaceuticals
 HSMN NewsFeed - 20 Aug 2009
Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
Devices Regenerative Medicine
 HSMN NewsFeed - 7 Aug 2009
Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
Devices Distribution
 HSMN NewsFeed - 27 Jul 2009
Halozyme Therapeutics Appoints Jonathan Leff, M.D. as Vice President, Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2009
Baxter and Halozyme Announce Completion of Patient Enrollment in Phase III Pivotal Trial of GAMMAGARD LIQUID with rHuPH20 Enzyme
Biopharmaceuticals
 HSMN NewsFeed - 8 Jul 2009
St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures
Devices Regenerative Medicine Cardiology
 HSMN NewsFeed - 23 Jun 2009
ThromCat(R) XT(TM) Thrombectomy Catheter System Receives CE Mark
Devices Interventional Regulatory
 HSMN NewsFeed - 7 May 2009
CorMatrix Cardiovascular to Present on its ECM Technology(TM) at the Annual Advanced Cardiac Techniques in Surgery (ACTS) Symposium in New York
Devices Cardiology
 HSMN NewsFeed - 23 Mar 2009
Medline Introduces MatriStem(TM) Extracellular Matrix That Taps Body's Own Capabilities to Repair Tissue
Devices Wound Care Distribution
 HSMN NewsFeed - 23 Mar 2009
ACell and Medline Announce Exclusive Marketing and Distribution Agreement for MatriStem(TM) Proprietary Bioscaffold for Wound Care
Devices Wound Care Distribution
 HSMN NewsFeed - 27 Jan 2009
SurModics and Nexeon MedSystems to Collaborate on Development of Novel Stent System for Renal Artery Disease
Devices Interventional
 HSMN NewsFeed - 10 Nov 2008
CorMatrix Announces Pre-Clinical Data Suggesting Next Generation ECM Technology(TM) Can Improve Cardiac Function
Devices Cardiology
 HSMN NewsFeed - 23 Sep 2008
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Sep 2008
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Aug 2008
Pharmaderm Annnounces the Arrival of KEROL(TM) ZX and KEROL(TM) Emulsion to Market
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 7 Jul 2008
Xclair(R) Reported to Be Safe and Effective in Study Published in European Journal of Dermatology
Biopharmaceuticals Dermatology Oncology
 HSMN NewsFeed - 8 May 2008
CorMatrix(R) Announces FDA 510(k) for Novel Biomaterial Implant for Intracardiac Repair
Devices Cardiology FDA
 HSMN NewsFeed - 9 Jan 2008
Ortec Shareholders Approve Corporate Name Change to Forticell Bioscience, Inc.
Regenerative Medicine Wound Care
 HSMN NewsFeed - 8 Jan 2008
Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2007
Halozyme Therapeutics Names Matthew R. Hooper Vice President, General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2007
Innocoll Enters Into Collaboration With TGR Biosciences for Development of a Novel Wound Healing Product
Biopharmaceuticals Drug Delivery Wound Care
 HSMN NewsFeed - 10 Sep 2007
Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Jul 2007
Ortec International: Dr. Costa Papastephanou Appointed CEO
Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 10 Jul 2007
SurModics and Paragon Intellectual Properties to Collaborate on FINALE(TM) Coated Prohealing Stent to Combat Late Stent Thrombosis
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 29 May 2007
Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2007
MTF Signs Marketing Agreement with ETHICON, Inc., for FlexHD(TM) Acellular Dermal Matrix
Devices
 HSMN NewsFeed - 16 Mar 2007
Micromet and TRACON Pharmaceuticals Sign Exclusive Worldwide License Agreement to Develop and Commercialize D93, a Humanized Antibody for Cancer Treatment
Biopharmaceuticals Licensing
 HSMN NewsFeed - 26 Feb 2007
Ortec Initiates Premarket Approval (PMA) Application Filing Seeking Approval for OrCel(R) in Treating Venous Leg Ulcers
Regenerative Medicine Wound Care FDA
 HSMN NewsFeed - 5 Dec 2006
Halozyme and Roche Enter Agreement for the Application of Enhanze, A Novel Technology to Improve Drug Delivery
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 8 Nov 2006
Dr. Hynda Kleinman Joins RegeneRx Medical and Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2006
Cook Biotech Remains Determined to Uphold Life Sciences Patent Rights
Devices Regenerative Medicine Litigation
 HSMN NewsFeed - 18 Oct 2006
AVI BioPharma Initiates NEUGENE Antisense Clinical Program in Coronary Artery Bypass Grafting
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 29 Sep 2006
FDA Issues Approvable Letter to Ortec for Use of Cryopreserved OrCel(R) in Epidermolysis Bullosa Patients' Hand Reconstructions and Donor Sites
Regenerative Medicine FDA
 HSMN NewsFeed - 12 Sep 2006
Ortec Announces Positive Results in Confirmatory Venous Leg Ulcer Trial
Devices Wound Care Regenerative Medicine
 HSMN NewsFeed - 17 Jul 2006
Cambrex and Ortec Submit to FDA a Humanitarian Device Exemption (HDE) for OrCel(R) to Treat Epidermolysis Bullosa Patients
Devices
 HSMN NewsFeed - 6 Jul 2006
Ortec Issues Update on Its Three Technology Platforms for Regenerative Medicine and Stem Cells
Regenerative Medicine
 HSMN NewsFeed - 22 May 2006
Cook Features Surgisis ES: New Product for the Treatment of Penile Curvature
Devices Urology
 HSMN NewsFeed - 15 May 2006
EntreMed Initiates Combination Phase 2 Clinical Trial With Panzem(R) NCD in Carcinoid Cancer
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 46

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 46 additional stories matching:
Cellular Matrix
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.